Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease [Phase 2]

View source ↗

Summary

Phase II trial protocol evaluating safety and efficacy of L2-01 versus placebo in Crohn's disease; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• L2-01

Snippet

Sponsor: L2 Bio, LLC | Conditions: Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD) | Phase 2 | Status: NOT_YET_RECRUITING